Mar 3, 2026 07:22AM
Mar 2, 2026 05:37PM
Mar 2, 2026 02:37PM
Mar 2, 2026 11:12AM
Mar 2, 2026 08:39AM
Jan 20, 2026 07:30AM
Dec 10, 2025 06:54AM Oppenheimer Upgrades Dyne Therapeutics (DYN) to Outperform
Dec 9, 2025 07:40AM
Dec 8, 2025 04:57PM
Dec 8, 2025 12:06PM
Dec 8, 2025 09:27AM
Dec 8, 2025 09:26AM
Dec 8, 2025 07:40AM
Nov 27, 2025 02:00AM Bernstein sees favorable risk-reward in this biotech stock
Nov 25, 2025 07:30AM
Nov 16, 2025 03:00PM
Nov 5, 2025 05:56PM
Oct 24, 2025 08:29AM
Oct 10, 2025 06:04AM
Sep 29, 2025 08:35AM
Sep 29, 2025 07:57AM Piper Sandler: 'Own Dyne Therapeutics (DYN) for DELIVER Data in Late 2025'
Sep 11, 2025 08:18AM
Aug 25, 2025 06:05AM
Aug 6, 2025 11:20AM
Aug 4, 2025 08:31AM
Jul 30, 2025 04:40PM
Jul 28, 2025 04:40PM
Jul 2, 2025 07:41AM Dyne Therapeutics (DYN) PT Lowered to $11.50 at Bernstein
Jun 30, 2025 04:05PM
Jun 30, 2025 04:02PM
Jun 25, 2025 04:12PM
Jun 18, 2025 06:43AM
Jun 17, 2025 09:39AM
Jun 17, 2025 07:01AM
Jun 5, 2025 12:44PM FDA Cell and Gene Therapy Roundtable 'bullish for the space' - Stifel
Jun 2, 2025 08:52AM
May 29, 2025 06:15AM
May 13, 2025 02:22PM
May 12, 2025 06:57AM
May 8, 2025 05:27PM
Apr 24, 2025 07:32AM
Apr 15, 2025 07:31AM Dyne Therapeutics Inc. (DYN) Announces Chief Business Officer and Chief Scientific Officer Appointments
Mar 26, 2025 05:58AM
Mar 20, 2025 04:25PM
Mar 20, 2025 04:11PM
Mar 17, 2025 09:39AM
Mar 17, 2025 08:08AM
Mar 17, 2025 07:56AM
Mar 17, 2025 07:53AM Chardan Capital Markets Reiterates Buy Rating on Dyne Therapeutics (DYN)
Mar 11, 2025 04:11PM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All